Navigation Links
Trinity Biotech plc to Announce Third Quarter 2008 Financial Results on October 31, 2008
Date:10/23/2008

Conference Call Scheduled for October 31, 2008 at 11:00 am EASTERN

DUBLIN, Ireland, Oct. 23 /PRNewswire-FirstCall/ -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter of fiscal year 2008 on Friday, October 31, 2008. The Company has scheduled a conference call for that same day, Friday, October 31, 2008, at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

USA: 1-877-356-5706

International: 1-706-679-3820

A simultaneous webcast of the call can be accessed at:

http://www.videonewswire.com/event.asp?id=52570

A replay of the call can be accessed until November 3, 2008 by dialing:

USA: 1-800-642-1687

International: 1-706-645-9291

Conference ID #: 69804141

The webcast of the call will be available for 30 days at:

http://www.videonewswire.com/event.asp?id=52570

About Trinity Biotech plc

Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.

For further information please see the company's website:

http://www.trinitybiotech.com.

Contact:

Ms. Niamh Long Joe Diaz, Joe Dorame and Robert Blum

Trinity Biotech plc Lytham Partners, LLC

Investor Relations Officer 602-889-7900

(800) 603-8076


'/>"/>
SOURCE Trinity Biotech plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Trinity Biotech plc to Announce Second Quarter 2008 Financial Results on July 22, 2008
2. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
3. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
4. Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
5. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
6. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
7. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
8. Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
9. SourceSolution Announces the Launch of Its Initiative to Simplify Outsourcing Decisions for Biotechnology and Pharmaceutical Companies
10. Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology
11. Axial Biotech Appoints Retired Roche Diagnostics Executive to Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... NEW YORK , Jan. 23, 2017  Today, ... to announce they have funded an important study that ... may prevent the onset of Alzheimer,s disease. This groundbreaking ... The Rockefeller University, led by Nobel Laureate Dr. ... cure for Alzheimer,s disease. Fisher Center scientists ...
(Date:1/23/2017)... 23, 2017  Spherix Incorporated (Nasdaq: SPEX ... fostering of technology and monetization of intellectual property, today ... Anthony Hayes , Chief Executive Officer ... continue to communicate with shareholders about the status of ... diligence on other patent assets that fit with our ...
(Date:1/23/2017)... , January 23, 2017 Atlas Genetics ... completion of its Series D financing, raising $35 million from ... investor, Wondfo Biotech. ... Development of the Atlas Genetics io® system has ... trachomatis (CT) test announced in February 2016.  This new Series ...
(Date:1/23/2017)... ... 2017 , ... AxioMed will be presenting its viscoelastic cervical ... Montego Bay, Jamaica from January 26-28th. “We’re excited to be presenting the benefits ... the simplicity of the surgical technique,” said Jake Lubinski, President of AxioMed. ...
Breaking Biology Technology:
(Date:1/18/2017)... MINNETONKA, Minn. , Jan. 18, 2017 /PRNewswire/ ... eClinical technology company that supports the entire spectrum ... 2016 has been another record-breaking year for the ... and market interest in MedNet,s eClinical products and ... to the tremendous marketplace success of ...
(Date:1/11/2017)... MOINES, Iowa , Jan. 11, 2017 ... industry first with the release of its patent-pending calibration ... quickly and reliably perform calibrations, securely upload data logs ... flexibility for the customer. "Fighting drunk driving ... only for the public at large, but also for ...
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):